Qube Research & Technologies (QRT)’s Diebold Nixdorf Incorporated DBD Stock Holding History

Qube Research & Technologies (QRT)’s Portfolio DBD Stock Details DBD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-21,951	Closed	-$1.16K	–	4425
2023 Q2	$1.16K	Buy	+21,951	New	+$13.9K	﹤0.01%	2302
2023 Q1	–	Sell	-71,157	Closed	-$101K	–	3159
2022 Q4	$101K	Sell	71,157 -280,741	-80%	-$602K	﹤0.01%	2003
2022 Q3	$859K	Buy	+351,898	New	+$1.17M	0.01%	1258
2022 Q2	–	Sell	-102,136	Closed	-$687K	–	3293
2022 Q1	$687K	Buy	+102,136	New	+$873K	0.01%	1370
2021 Q1	–	Sell	-23,991	Closed	-$256K	–	2546
2020 Q4	$256K	Sell	23,991 -39,356	-62%	-$357K	﹤0.01%	1421
2020 Q3	$484K	Buy	+63,347	New	+$466K	0.01%	1047
2020 Q2	–	Sell	-22,246	Closed	-$78K	–	2068
2020 Q1	$78K	Buy	+22,246	New	+$188K	﹤0.01%	992

Qube Research & Technologies (QRT)'s DBD Position: Q3 2023 in Review

Qube Research & Technologies (QRT) sold out of Diebold Nixdorf Incorporated (DBD) in Q3 2023, closing a stake of 21,951 shares — an estimated $1.16K sold.

Qube Research & Technologies (QRT) first reported a position in DBD in Q1 2020 and held it in 7 quarters. The position peaked at $859K in Q3 2022. 0 funds tracked by Wall St. Rank hold DBD as of Q3 2023.

Qube Research & Technologies (QRT) reported no remaining Diebold Nixdorf Incorporated position as of Q3 2023 after selling out during the quarter.
Qube Research & Technologies (QRT) sold 21,951 Diebold Nixdorf Incorporated shares in Q3 2023, an estimated $1.16K.
Qube Research & Technologies (QRT) first reported a position in Diebold Nixdorf Incorporated in Q1 2020 and held it in 7 quarters.
Qube Research & Technologies (QRT)'s Diebold Nixdorf Incorporated position peaked at $859K in Q3 2022.
0 funds tracked by Wall St. Rank held Diebold Nixdorf Incorporated as of Q3 2023.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q3 2023, filed 13 Nov 2023.